Citation: Tp. Johnston et Wk. Palmer, THE EFFECT OF PRAVASTATIN ON HEPATIC 3-HYDROXY-3-METHYLGLUTARYL COA REDUCTASE OBTAINED FROM POLOXAMER 407-INDUCED HYPERLIPIDEMIC RATS, Pharmacotherapy, 17(2), 1997, pp. 342-347
Citation: Wk. Palmer et al., THE POLOXAMER 407-INDUCED HYPERLIPIDEMIC ATHEROGENIC ANIMAL-MODEL, Medicine and science in sports and exercise, 29(11), 1997, pp. 1416-1421
Citation: Tp. Johnston et Wk. Palmer, EFFECT OF POLOXAMER-407 ON THE ACTIVITY OF MICROSOMAL 3-HYDROXY-3-METHYLGLUTARYL-COA-REDUCTASE IN RATS, Journal of cardiovascular pharmacology, 29(5), 1997, pp. 580-585
Citation: C. Li et al., DISPOSITION OF POLOXAMER-407 IN RATS FOLLOWING A SINGLE INTRAPERITONEAL INJECTION ASSESSED USING A SIMPLIFIED COLORIMETRIC ASSAY, Journal of pharmaceutical and biomedical analysis, 14(5), 1996, pp. 659-665
Authors:
PORTER JA
CARTER BL
JOHNSTON TP
PALMER WK
Citation: Ja. Porter et al., EFFECT OF PRAVASTATIN ON PLASMA-LIPID CONCENTRATIONS IN POLOXAMER 407-INDUCED HYPERLIPIDEMIC RATS, Pharmacotherapy, 15(1), 1995, pp. 92-98
Citation: Mj. Ladu et Wk. Palmer, EXPRESSION OF LIPOPROTEIN-LIPASE DURING DIFFERENTIATION OF CULTURED L6 MUSCLE-CELLS, Canadian journal of physiology and pharmacology, 72(3), 1994, pp. 243-247
Citation: Tp. Johnston et Wk. Palmer, MECHANISM OF POLOXAMER 407-INDUCED HYPERTRIGLYCERIDEMIA IN THE RAT, Biochemical pharmacology, 46(6), 1993, pp. 1037-1042